PP
DNA icon

PDT Partners’s Ginkgo Bioworks DNA Stock Holding History

PDT Partners’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-16,168
Closed -$134K – 551
2025
Q4 		$134K Sell
16,168
-23,632
-59% -$254K 0.01% 534
2025
Q3 		$580K Sell
39,800
-28,634
-42% -$343K 0.04% 433
2025
Q2 		$770K Sell
68,434
-316,719
-82% -$2.45M 0.04% 463
2025
Q1 		$2.2M Buy
385,153
+196,350
+104% +$2M 0.16% 227
2024
Q4 		$1.85M Buy
188,803
+41,641
+28% +$357K 0.16% 227
2024
Q3 		$1.2M Buy
+147,162
New +$1.47M 0.11% 325

Other funds holding DNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PDT Partners's DNA Position: Q1 2026 in Review

PDT Partners sold out of Ginkgo Bioworks (DNA) in Q1 2026, closing a stake of 16,168 shares — an estimated $134K sold.

PDT Partners first reported a position in DNA in Q3 2024 and held it in 6 quarters. The position peaked at $2.2M in Q1 2025. 174 funds tracked by Wall St. Rank hold DNA as of Q1 2026.

  • PDT Partners reported no remaining Ginkgo Bioworks position as of Q1 2026 after selling out during the quarter.
  • PDT Partners sold 16,168 Ginkgo Bioworks shares in Q1 2026, an estimated $134K.
  • PDT Partners first reported a position in Ginkgo Bioworks in Q3 2024 and held it in 6 quarters.
  • PDT Partners's Ginkgo Bioworks position peaked at $2.2M in Q1 2025.
  • 174 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2026.

Based on PDT Partners's 13F filing for Q1 2026, filed 15 May 2026.